Inhibition of heat-shock protein 90 reduces Ebola virus replication
- 1 August 2010
- journal article
- Published by Elsevier BV in Antiviral Research
- Vol. 87 (2), 187-194
- https://doi.org/10.1016/j.antiviral.2010.04.015
Abstract
No abstract availableKeywords
Funding Information
- NIH (AI064606)
This publication has 38 references indexed in Scilit:
- Brain-Permeable Small-Molecule Inhibitors of Hsp90 Prevent α-Synuclein Oligomer Formation and Rescue α-Synuclein-Induced ToxicityJournal of Pharmacology and Experimental Therapeutics, 2009
- Heat-shock Protein 90 Is Essential for Stabilization of the Hepatitis C Virus Nonstructural Protein NS3Journal of Biological Chemistry, 2009
- Heat Shock Protein 90 as a Drug Target: Some Like It HotClinical Cancer Research, 2008
- Discovery and development of heat shock protein 90 inhibitorsBioorganic & Medicinal Chemistry, 2008
- Chaperone activation of the hepadnaviral reverse transcriptase for template RNA binding is established by the Hsp70 and stimulated by the Hsp90 systemNucleic Acids Research, 2007
- Involvement of Hsp90 in Assembly and Nuclear Import of Influenza Virus RNA Polymerase SubunitsJournal of Virology, 2007
- Antiviral activity and RNA polymerase degradation following Hsp90 inhibition in a range of negative strand virusesVirology, 2007
- Evolutionary constraints on chaperone-mediated folding provide an antiviral approach refractory to development of drug resistanceGenes & Development, 2007
- Hsp90 inhibitors suppress HCV replication in replicon cells and humanized liver miceBiochemical and Biophysical Research Communications, 2006
- Pathogenesis of Ebola Hemorrhagic Fever in Cynomolgus MacaquesThe American Journal of Pathology, 2003